Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SUMATRIPTAN
- Habituation of the Nociceptive Blink Reflex in Experimentally Induced Migraine Attack
- Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin
- Minidosing Lysergic Acid Diethylamide (LSD) for Chronic Cluster Headache
- Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
- Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache
- Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates
- Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial
- Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks
- Sumatriptan and Glucose
- A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.
- Effectiveness of Nebulized Dexmedetomidine for Treatment of Obstetric Post-Dural Puncture Headache
- Is Theophylline More Effective Than Sumatriptan in the Treatment of Post-dural Puncture Headache
- PACAP38 Induced Headache, Migraine and Flushing in Patients With Migraine
- PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea
- The Effect of Sumatriptan and Placebo on CGRP Induced Headache
- The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache
- Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
- A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants
- Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)
- Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
- Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers
- Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
- Understanding the Pathophysiology of Migraine Pain
- Comparative Bioavailability Study of Omexa Sumatriptan vs. Imitrex® in Healthy Volunteers
- Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation
- An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
- Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan
- Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine
- Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study.
- Safety and Efficacy Study of SOM230 s.c. in Cluster Headache
- Investigation of Vascular Inflammation in Migraine Using Molecular Nano-imaging and Black Blood Imaging MRI
- Aminophylline for Patients With Post-Dural Puncture Headache
- The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache
- The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache
- Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches
- A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis
- Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan
- Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo
- Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study
- Sumatriptan as Treatment for Post-traumatic Headache
- Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment
- Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
- Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache
- Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura
- Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy
- Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
- Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects
- Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance
- Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine
- Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex
- Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine
- Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults
- A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
- Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
- Drug Use Investigation for IMIGRAN Tablet
- Treximet ™ Pharmacy Budget Impact Model Database Validation Study
- CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
- A Pilot Study of Demand Valve Oxygen Inhalation Therapy for Cluster Headache
- Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions
- Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine
- Ictal and Interictal Inflammatory Markers in Migraine
- Trial of Comprehensive Migraine Intervention
- Sumatriptan and Naratriptan Pregnancy Registry
- Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
- Treximet Early Intervention Adolescent Migraine
- A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.
- Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
- Study of NXN 188 for the Treatment of Migraine With Aura
- Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
- MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)
- A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
- Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
- Efficacy and Safety of BGG492 in the Treatment of Migraine
- Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura
- An Open-label, Randomized, 3-period Crossover Study to Evaluate Sumatriptan Pharmacokinetics for a TREXIMA™ (Sumatriptan Succinate / Naproxen Sodium) Tablet Followed by IMITREX® (Sumatriptan Succinate)
- Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions
- Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions
- Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions
- Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions
- Migraine Study in Adolescent Patients
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months
- Study in Participants With Acute Migraines Headaches
- Cluster Headache Cortivazol Injection (CHCI)
- A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months
- Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.
- The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
- Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
- Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers
- Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)
- Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
- Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg
- A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs
- TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults
- Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
- A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
- Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents
- Comparing Naproxen to Sumatriptan for Emergency Headache Patients
- To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
- To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
- Neuropeptides in the Humane Intra- og Extracerebral Circulation.
- Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache
- TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)
- TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine
- A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2)
- A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
- Functional MRI (fMRI) in CGRP Induced Migraine
- Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
- Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
- Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA)
- Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
- Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
- Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
- Prophylactic Treatment of Episodic Cluster Headache
- Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines
Clinical trials list
click for details